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Abstract
Cigarette smoking (CS) has been strongly linked to several health conditions including heart
disease, lung cancer, and other respiratory and circulatory ailments. Deleterious effects of cigarette
smoking on skin have also been well documented, but unlike effects on other organs, damage does
not depend upon inhalation. The upper layer of the skin, the stratum corneum (SC) (rich in
cholesterol fatty acids and ceramide) is very susceptible to damage induced by exposure to
environmental stressors that can modify its lipid composition and thereby affect its function of
protecting skin from dehydration. Scavenger Receptor B1 (SR-B1) is involved in uptake of
cholesterol in several tissues including skin. We previously demonstrated that CS exposure
induces formation of aldehydes (HNE) adducts that decrease SR-B1 expression. As topical
resveratrol, a well-known polyphenolic stilbene, has been demonstrated to show benefits against
skin disorders, we investigated its possible role as a protective agent against CS-induced reduction
of SR-B1 expression in cutaneous tissue. In this study, we have demonstrated that resveratrol at
the doses ranging from 0.5 to 10μM is not toxic, is able to increase SR-B1 protein levels in a dose-
dependent manner in human keratinocytes. Moreover, when the cells that were pre-treated with
different doses of resveratrol, were exposed to CS, the loss of SR-B1 was prevented in a dose
dependent manner. In addition, in keratinocytes, resveratrol was also able to prevent an increase in
HNE protein adducts induced by CS. In particular resveratrol was able to prevent HNE-SRB1
adducts formation. Thus, resveratrol appears to be a natural compound that could provide skin
with a defense against exogenous stressors by protecting the essential cholesterol receptor, SR-B1.
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Introduction
Because of its critical location, cutaneous tissue is the first barrier against environmental
insults such as UV radiation, CS, diesel fuel exhaust, halogenated hydrocarbons, heavy
metals and O3 [1]. Within the skin, the stratum corneum (SC) has been identified as the
main target of oxidative damage. As the outer skin barrier, the SC has important functions,
limiting transepidermal water loss and posing a mechanical barrier to penetration by
exogenous chemicals and pathogens. It comprises a unique two-compartment system of
structural, non-nucleated cells (corneocytes) embedded in a lipid enriched intercellular
matrix, forming stacks of bilayers that are rich in ceramides, cholesterol and free fatty acids
[2].
Cholesterol represents about one-quarter of the lipid content of the SC. It is an essential
component for all cells. In the skin, cholesterol is implicated in corneocyte desquamation
and cohesion and keratinocyte differentiation. In keratinocytes, cholesterol is required to
form lamellar bodies that play a key role in maintaining barrier function in optimal
conditions [2]. One of the main pathways by which cholesterol can be taken up by the
tissues is via scavenger receptor class B type I (SR-BI) that mediates the cholesterol flux in
a bidirectional manner dependent upon the cholesterol gradient [3]. SR-BI, a transmembrane
protein, mediates selective lipid uptake from hydrophobic lipoprotein cores [4,5] and
facilitates the cellular uptake of cholesterol (mainly cholesteryl esters) by intervening in the
binding of the lipoprotein with the outer surfaces of cells. This happens through a process in
which the cholesterol esters are internalized without the net internalization and degradation
of the lipoprotein itself although Silver et al. have shown that in polarized liver cells SR-B1
is able to facilitate uptake of the whole HDL particle via a transcytosis process [6]. Among
environmental insults to which cutaneous tissue is exposed, CS, particularly the oxidative
compounds that derive from the combustion of cigarettes, can affect skin physiology [7, 8].
In a previous study we showed that exposure to CS, through its stimulation of endogenous
H2O2 production, induced post-translational modifications of SR-B1 with the consequent
loss of the receptor. Furthermore, this loss may play a role in altered skin physiology
induced by CS exposure [9].
Resveratrol (3,5,4’-trihydroxy-trans-stilbene) is a natural polyphenolic stilbene found in
grape skin, nuts, pomegranate and herbal medicines, including Polygonum cuspitatum.
Resveratrol has been shown to exhibit various biochemical activities including regulation of
the cell cycle, stimulation of endothelial nitric oxide synthase, and inhibition of platelet
aggregation. Furthermore, several studies have reported that resveratrol protects against
oxidative damage by enhancing the expression of antioxidant genes, such as heme
oxygenase-1 and glutamate cysteine ligase [10, 11, 12].
Natural compounds have been used to regulate serum lipid concentration to reduce the
incidence of hyperlipidemia and atherosclerosis. As resveratrol is a natural polyphenol that
can induce antioxidant enzymes, it has been suggested to be responsible for the protective
effect in different pathologies characterized by hyperlipidemia [13] In our previous study
[14] a decrease of SR-B1 protein levels induced by CS through post-transductional
modification (HNE adduct formation) was shown. Thus, the present work is aimed at
evaluating the possible protective effect of resveratrol in preventing the CS-induced
decrease of keratinocytes SR-B1 levels.
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Material and Methods
METHODS
Cell Culture and Treatments—HaCaT cells, (a cell line gift from Dr. F. Virgili), were
grown in Dulbecco’s modified Eagle’s medium High Glucose (Lonza, Milan, Italy),
supplemented with 10% FBS, 100 U/ml penicillin, 100 μg/mL streptomycin and 2 mM L-
glutamine as previously described [15]. Cell suspension containing 10 or 1 × 105 viable
cells/ml were used. Cells were incubated at 37 °C for 24 h in 95% air/5% CO2 until 80%
confluency.
HaCaT cells were pretreated (24h) with resveratrol [0.5, 1, 5 and 10 μM] (purity ≥ 99%
[GC], Sigma Aldrich, Milan, Italy), then the media was removed before CS exposure, and
then the cells were resuspended in DMEM medium supplemented with 10% FBS. After
treatments with different doses and various times, cells were collected by centrifugation for
the several assays described below.
CS Exposure—HaCaT cells were exposed to fresh CS in an exposure system that
generated CS by burning one UK unfiltered research cigarette (12 mg tar, 1.1 mg nicotine)
using a vacuum pump to draw air through the burning cigarette and leading the smoke
stream over the cell cultures [16]. Briefly, overnight serum-starved HaCaT cells in culture
were placed with lids removed in a 37 °C chamber having a volume of 0.0127 m3, smoke
from one cigarette was introduced into the chamber by readmitting air (a decrease of ~12.7
cm Hg over ~30 s) in the chamber after achieving a partial vacuum (63.5 cm Hg) via a short
piece of tubing holding a lit cigarette (UK research cigarette; 12 mg tar, 1.1 mg nicotine).
Cells were exposed for 50 min to CS. Control cells were exposed to filtered air for the same
duration (50 min). After the exposure (air or CS) fresh media was added to the cells.
Cellular Viability—Viability studies were performed 24 h after treatments by LDH release
assay. The LDH release was measured by enzymatic assay: in the first step NAD+ is reduced
to NADH by the LDH-catalyzed conversion of lactate to pyruvate; in the second step the
catalyst (diaphorase) transfers a H- from NADH to the tetrazolium salt, which is reduced to
the formazan.
Before LDH release measurement, the cells were lysed with 0.1% (V/V) Triton X-100 in
culture media for 30 min at 37°C to obtain a representative maximal LDH release as the
positive control with 100% toxicity. The amounts of LDH in the supernatant were
determined and calculated according to kit instructions (Roche, Milan, Italy). Color changes
were measured at 490 nm.
Immunocytochemistry—HaCaT cells were grown on cover slips at a density of 1 x 105
cell/ml, and after CS exposure fixed in 4% paraformaldehyde in PBS for 30 min at room
temperature (RT). Cells were permeabilized for 15 min at room temperature with PBS
containing 1% BSA, 0.2% Triton X-100, and 0.02% sodium azide, then the cover slips were
blocked in PBS containing 1% BSA, 0.2% Nonidet P-40 and 0.02% sodium azide at room
temperature for 1 h at RT. Cells were incubated with a mixture of goat anti-HNE (1:250)
and rabbit anti-SR-B1 (1:250) for 1 h and then were incubated with a mixture of anti-goat
(1:100) and anti rabbit (1:100) in PBS containing 0.5% BSA for 1 h at RT. Nuclei were
stained with 1 μg/ml DAPI (Molecular Probes) for 1 min after removal of secondary
antibodies. Cover slips were mounted onto glass slides using anti-fade mounting medium
1,4 diazabicyclooctane in glycerin (DABCO) and examined by the Zeiss Axioplan2 light
microscope equipped with epifluorescence at 40× magnification. Negative controls for the
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immunostaining experiments were performed by omitting primary antibodies. Images were
acquired and analyzed with Axio Vision Release 4.6.3 software.
Western blot Analysis—Total cell lysates were extracted in solubilization buffer
containing 50 mM Tris (pH 7.5), 150 mM NaCl, 10% glycerol, 1% Nonidet P-40, 1 mM
EGTA, 0.1% SDS, 5 mM N-ethylmaleamide (Sigma-Aldrich Corp.), protease and
phosphatase inhibitor cocktails (Sigma–Aldrich Corp.) as described before [16].
Cells were harvested by centrifugation and proteins concentration was determined by the
method of Bradford (Biorad Protein assay, Milan, Italy). Samples of 60 μg protein in 3X
loading buffer (65 mM Tris base, pH 7.4, 20% glycerol, 2% sodium dodecyl sulfate, 5% β-
mercaptoethanol and 1% bromophenol blue) were boiled for 5 min, loaded onto 10%
sodium dodecyl sulphate–polyacrylamide electrophoresis gels and separated by molecular
size. The gels were then electro-blotted onto nitrocellulose membranes which were then
blocked for 1 h in Tris-buffered saline, pH 7.5, containing 0.5% Tween 20 and 5% milk.
Membranes were incubated overnight at 4 °C with the primary antibody, rabbit anti SR-B1
(Novus Biologicals, Inc.; Littleton, CO) or goat anti-HNE (Millipore, Milan, Italy). The
membranes were then incubated with horseradish peroxidase-conjugated secondary antibody
for 1 h, and the bound antibodies were detected using chemiluminescence (BioRad, Milan,
Italy). The blots were then stripped and reprobed with β-actin (Cell Signalling; Celbio,
Milan, Italy) as the loading control. Images of the bands were digitized and the densitometry
of the bands were performed using Image-J software.
Quantitative real-time PCR—Total RNA was extracted, using an AURUM total RNA
Mini Kit with DNAse digestion (Bio-Rad, Laboratories Inc., Benicia, CA, USA), from
2x105 HaCaT cells for each experimental condition, according to the manufacturer’s
recommended procedure. First-strand cDNA was generated from 1 μg of total RNA using
the iScript cDNA Synthesis Kit (Bio-Rad). The primer pairs (Table 1) capable of
hybridization with unique regions of the appropriate gene sequence were obtained from the
Real-time PCR GenBank Primer and Probe Database Primer Bank, RT primerDB [17].
Quantitative real-time PCR (qPCR) was performed using SYBR Green on the iQ5
Multicolor Real-time PCR Detection System (Bio-Rad). The final reaction mixture
contained 300 nM of each primer, 1μL of cDNA and 7ul of iQ SYBR Green Supermix (Bio-
Rad), with RNAse-free water being used to bring the reaction mixture volume to 15 μl. All
reactions were run in triplicate. Real-time PCR was initiated with a 3-min hot-start
denaturation step at 95°C, and then performed for 40 cycles at 95°C for 10 s and at 60°C for
20 s. During the reaction, fluorescence, and therefore the quantity of PCR products, was
continuously monitored by Opticon Monitor 3 software (Bio-Rad). Primers were initially
used to generate a standard curve over a large dynamic range of starting cDNA quantities,
permitting calculation of the amplification efficiency (a critical value for the correct
quantification of expression data) for each of the primer pairs. Ribosomal protein L13a
(RPL13a), L11a (RPL11a) and GAPDH, were employed as reference genes. As previously
described, samples were compared using the relative cycle threshold (CT) method [18].
After normalization to more stable mRNA RPL13a, RPL11a and GAPDH, the fold increase
or decrease was determined with respect to control, using the formula 2-ΔΔCT, where ΔCT
is: (gene of interest CT)(reference gene CT), and ΔΔCT is (ΔCT experimental) (ΔCT
control).
Statistical Analysis—For each of the variables tested, two-way analysis of variance
(ANOVA) was used. A significant effect was indicated by a P-value < 0.05. Data are
expressed as mean ± S.D. of triplicate determinations obtained in 5 separate experiments.
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RESULTS
Resveratrol cytotoxicity—Cytotoxicity of resveratrol ranging from 0.5 to 10 μM was
evaluated in the HaCaT cell line by LDH release. As shown in Fig.1, there were no
significant differences between the resveratrol treated cells and the control (ethanol 0.1%)
after 24 h. LDH release was around 20% in all sample, Triton X was used as positive control
(100%).
Resveratrol increased SR-B1 protein levels—To evaluate whether resveratrol
treatment affect the SR-B1 protein level, we have performed Western blot analysis in
HaCaT cells lysates. As shown in Fig.2, after 24 h of resveratrol treatment SR-B1 protein
levels increased in a dose-dependent manner. The increase in the SR-B1 protein levels was
already detectable after treatment with 1μM resveratrol (2 fold) and showed its highest
increase at 5μM (2.3 fold); no further induction of the SR-B1 was observed with higher
doses (10 μM).
Resveratrol prevents SR-B1 decrease by CS exposure—In our previous work we
have demonstrated that CS induces a decrease of the SR-B1 level in human keratinocytes as
a consequence of increased oxidative stress [14], therefore we wanted to evaluate whether
resveratrol treatment was able to protect against CS induced loss of SR-B1. As shown in
Fig.3, 24 h after CS exposure, the protein levels of SR-B1 decreased significantly (circa
60%). On the other hand, pretreatment with resveratrol prevented the loss of the SR-B1
induced by CS in a dose dependent manner, starting from 1μM and reaching a maximum
effect at 10μM resveratrol.
Effect of CS and Resveratrol on SR-B1 expression—To understand whether or not
the effect of resveratrol on the SR-B1 protein levels was also a consequence of increased
new transcription, we measured mRNA levels before and after resveratrol treatment. As
shown in Fig.4A, SR-B1 mRNA levels increased significantly upon CS exposure (2 fold
after 50 min). On the other hand, the opposite trend was observed in the resveratrol treated
cells (Fig.4B), where the induction of mRNA was completely abolished, while, when the
cells were treated with only resveratrol, SRB1 mRNA increased (panel C). Thus, it appears
that resveratrol prevents the loss of the SR-B1 protein rather than induces replacement of the
SR-B1 through transcription.
Resveratrol prevented the formation of HNE modified proteins induced by CS
—Among the most reactive compounds present and generated by CS are the alpha-beta
unsaturated aldehydes such as HNE. We therefore evaluated HNE adducts formation in
keratinocytes exposed to CS with or without resveratrol pretreatment. As shown in Fig.5A,
after CS exposure there was a significant increase of HNE protein adducts levels, and this
effect was noticeable shortly after exposure (50’). Pretreatment with resveratrol produced
dose-dependent prevention of CS-induced HNE protein adducts. This effect was observed
with as little as 1μM resveratrol, but was more evident with higher resveratrol
concentrations with a maximum effect at 10 μM. To evaluate the effect of resveratrol on
HNE protein adducts formation, the cells were retreated with resveratrol at different doses
and HNE adducts were determined. As shown in Fig.5B, resveratrol pretreatment was able
to decrease the steady levels of cellular HNE proteins adducts, this effect was more evident
at 5 and 10 μM concentration.
Resveratrol decreased the formation of HNE/SR-B1 adducts induced by CS—
In our previous work we have reported that CS induces HNE/SR-B1 adducts [14]. Therefore
in this study we evaluated by immunofluorescence and immunoprecipitation techniques
whether resveratrol pretreatment was able to affect the formation of HNE/SR-B1 adducts in
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cells exposed to CS. As shown in Fig.6A, after CS exposure, there was a clear increase of
HNE adducts (left column, green color) and a decrease in SR-B1 levels (central column, red
color). The yellow color of merged images (right column) is indicative of the co-localization
of HNE adduct and SR-B1, suggesting the formation of HNE-SR-B1 adducts. When the
cells were pretreated with resveratrol and then exposed to CS, HNE adduct formation was
less evident than that observed in the cells exposed to CS alone (bottom left panel).
Moreover, the decrease in SR-B1 was prevented (bottom central panel) with very
diminished co-localization (yellow) as can be observed in the bottom right panel. These data
were also confirmed by immunoprecipitation assay as shown in Fig.6B, where
immunoprecipitation of SR-B1 and immunoblotting for HNE shows a clear decrease of
HNE-SR-B1 adducts after resveratrol pretreatment of circa 50–60%.
DISCUSSION
The purpose of this study was to evaluate the potential protective effect of resveratrol in CS
induced loss of SR-B1 in keratinocytes. This work was a continuation of our previous work
in which we demonstrated that CS was able to affect SR-B1 levels via post-translational
modification as a consequence of increased H2O2 production.
Resveratrol, a polyphenolic stilbene ((E)-5-(4-h-hydroxystyryl)benzene-1,3-diol), was first
isolated in the 1940s from white hellebores by Takaoka, and later from the Japanese
knotweed Polygonum cuspidatum by Nonomura [19]. It is also found in some red wines and
other components of the diet [20].
Due to several highly publicized claims and ‘low behaviors’ by a few investigators,
resveratrol has been given a great amount of attention, some of which has been
controversial. The French paradox is the apparently paradoxical association between lower
cardiovascular disease despite a supposedly fat-laden French diet in which red wine
consumption has been labeled as the ‘savior’ from fois gras [21, 22]. On closer
investigation, it appeared that resveratrol was perhaps the active phytochemical in red wine.
The concept of the French paradox has since been challenged, but the apparent
cardiovascular protective properties of wine polyphenols, which have not been a principal
subject of controversy, have been attributed to its inhibition of LDL cholesterol
peroxidation, modulation of nitric oxide production, and ability when still in the gut with
lipid-derived radicals [23–25].
Indeed, there has been an enormous amount of publications on the beneficial effects of
resveratrol, showing its ability to prevent cancer formation [26] inhibit inflammation [27]
and provide several other positive effects including cardiovascular protection [28] and
neuroprotection [29]. Nonetheless, another controversy surrounds claims that resveratrol
could extend lifespan by mimicking, without the need for self-denial, the benefits of a
calorie-restricted diet [30–32]. The claims, particularly as the last failed to match its
promise, has diminished enthusiasm for the compound despite those effects that appear to
have stood up to further investigation.
In investigating the mechanism of how resveratrol acts, many have turned to studies of
signaling in cellular models. The main concern about most in vitro cellular studies of the
biological effect of resveratrol and other polyphenols has been the high concentration
required to produce protection, as these would never be reached in vivo. It has been argued
that following human oral absorption, resveratrol is very rapidly absorbed, mainly through
transepithelial diffusion [33]. But, regardless of issues of absorption and fate of ingested
resveratrol, in our studies that model topical application, the question of sufficient
bioavailability was moot. Indeed, in this model, other factors affecting the delivery of
resveratrol did not need to be considered. In addition the role of resveratrol in protecting
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skin inflammation in vivo has been elegantly demonstrated by the group of Surh, where
animals feed with resveratrol showed a decreased activation of NF-κB and reduced COX2
expression [34]. Cutaneous tissue is continuously exposed to outdoor stressors such as UV,
O3 and CS [35, 36]. The noxious effects of CS on skin have been now well recognized and
its role in the pathogenesis of several pathologies is now well accepted [37, 38]. One of the
mechanisms through which CS induces its noxious effect is through its ability to induce
oxidative stress and generate bioactive products from lipid peroxidation including HNE.
HNE derives from the oxidation of ω-6 polyunsaturated acids (PUFAs), essentially
arachidonic and linoleic acid. It is a highly electrophilic molecule that primarily reacts with
the amino acids cysteine, histidine and lysine, when free or as components of proteins.
Cysteine, particularly as a thiolate (S−), and neutral imidazole and amino groups undergo
Michael addition reactions to the C=C double bond of HNE.
In the present work, we have shown that, in keratinocytes, resveratrol was able to prevent
CS induced SR-B1 protein modification by decreasing the formation of SR-B1 – HNE
protein adducts. This protective effect can be achieved via multiple mechanisms. Although
scavenging of reactive oxygen species has been claimed for resveratrol [39], within cells the
induction of gene expression of phase II enzymes, such as heme oxygenase-1 or glutamate
cysteine ligase, through activation of the transcription factor Nrf2 [40] or direct conjugation
with HNE, as has been shown in epithelial lung cells [41], is more likely. In the present
study we did not evaluate all the possible pathways mentioned above and we cannot exclude
that more than one “defensive” mechanism is activated by resveratrol in keratinocytes
exposed to CS.
We performed our study on HaCaT cells, a line of human non-tumorigenic skin epithelial
cells, which represent a suitable, well-recognized and largely employed model of human
skin keratinocytes [42] as they retain most of the functional differentiation properties of
normal keratinocytes. In addition HaCaT cells in culture can revert back and forth between a
differentiated and basal state upon changes in calcium concentration in the medium and
express differentiation markers indicating their state [43, 44]. Our previous study [14] by
demonstrating that CS adversely affects SR-B1 levels via posttranslational modification as
demonstrated through immunoprecipitation and Western blotting. Here, we extend the
investigation by showing that pre-treatment with resveratrol prevented the CS-induced loss
of SR-B1. This is not the first finding showing that resveratrol can be effective in cutaneous
topical usage. The root of Polygonum cuspidatum, which contains resveratrol, also called
Ko-jo-kon in Japanese, was used in traditional Japanese and Chinese medicine to treat
dermatitis [45]. In addition, resveratrol has also been shown to be chemopreventive against
skin cancer by inhibiting carcinogenesis at all three stages, initiation, promotion, and
progression [43, 46, 47].
Although most antioxidants cannot reach concentrations within cells that would allow them
to function as chemical antioxidants, topical application may permit the required high
concentration to compete with radicals at the cell surface. Certainly, outside the cell,
resveratrol would have less competition and could act as a scavenger of reactive species.
But, it is also known, that polyphenols, can be converted to electrophiles and thereby
activate phase II enzyme as a protective mechanism [48]. So, there may be two contributing
factors that allow exogenous resveratrol to protect keratinocytes, direct scavenging of
radicals, which is usually only possible with vitamin E, and reaching high enough
concentrations to induce antioxidant defenses.
The role of SR-B1 in protecting cutaneous tissue could be related to its ability to regulate
cholesterol trafficking as suggested by the work Tsuruoka et al. [49] in which SR-B1 levels
decreased as the keratinocytes differentiated but increased after insults, such as tape
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stripping, where the epidermis required more lipids to restore the permeability barrier in the
SC. SR-B1 appears to possess additional functions in skin. Abnormal SC lipid profiles have
been identified in several scaly skin diseases including ichtyosis [50] and atopic dermatitis.
Atopic dermatitis is associated with abnormalities in the amounts of SC lipids and barrier
function. Imokawa et al. [51] reported that in atopic dermatitis there was a marked reduction
in the amount of CER in the forearm skin lesions compared with that of healthy individuals
of the same age. These clinical studies indicated that alterations of SC lipid profile are
responsible for the diminished permeability barrier function.
Although not directly connected to its ability to recognize HDL, SR-B1 has been shown to
regulate calcium permeability in lymphocytes and be involved in bacteria recognition and
vitamin E tissue uptake [3]; in addition it is now shown to be present in several tissues
beside liver such as, lung, ovary, testis, brain, spleen, kidney [52] and, recently, even skin
[50].
CS exposure was able to regulate SR-B1 also at the transcriptional level, and this effect was
not observed when the cells were pretreated with resveratrol. This result may have been
expected as SR-B1 is regulated by zinc-finger transcription factors Sp1, which can be
activated by oxidative stress [53]. We therefore suggest that the role of resveratrol in
preventing the loss of SR-B1 was due to either its direct or indirect increase in antioxidant
protection that decreased the formation of HNE adducts. As noted above, topical application
of resveratrol may allow it to reach high enough concentrations to act as a radical scavenger
while its activation of phase II enzyme induction would increase the capacity to both prevent
HNE formation and eliminate HNE when it is formed. Phase II induction increases the
capacity to eliminate H2O2 and lipid hydroperoxides as well as accelerate HNE removal by
conjugation and other metabolic routes [54]. In fact, in our recent work we have
demonstrated that when HaCaT cells were exposed to CS give rise to a vicious cycle in
which the aldehydes formed by CS led to the activation of NOX enzyme with increased
H2O2 production. This leads to Fenton chemistry-dependent initiation of lipid peroxidation
of cytosolic membrane lipids. A chain reaction in which increased formation of lipid
peroxidation products including HNE and other aldehydes are produced then causes this
cycle to spiral out of control [14].
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Cigarette Smoke affect skin physiology by decreasing
SRB1 levels SRB1 forms adducts with 4HNE and then is ubiquitinated
Resveratrol prevents CS induced SRB1 loss by preventing the formation of
SRB1-4HNE adducts
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Fig. 1.
Cytotoxicity of resveratrol ranging from 0.5 to 10 μM after 24 h was evaluated in HaCaT
cell line by LDH release assay. Data are expressed as percentage of Triton X-100 [=positive
control] (averages of five different experiments ± SEM).
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Fig. 2.
Effect of resveratrol treatment on SR-B1 protein levels. Representative Western blot in the
upper panel. Quantification of the SR-B1 bands is shown in the bottom panel. Data are
expressed in arbitrary units (averages of five different experiments ± SEM, *p < 0.05). β-
actin was used as loading control.
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Fig. 3.
Effect of resveratrol pre-treatment on decreased SR-B1 levels induced by CS.
Representative Western blot in the upper panel. Quantification of the SR-B1 bands is shown
in the bottom panel. Data are expressed in arbitrary units (averages of five different
experiments ± SEM, * vs. control; # vs. CS; p < 0.05). β-actin was used as loading control.
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Fig. 4.
Effect of resveratrol with or without CS exposure on SR-B1 mRNA expression. Results are
expressed in % 2–ΔΔCT with respect to the control value. Data are expressed as mean ± SEM
of five independent experiments, * vs. control; p < 0.05.
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Fig. 5.
Effect of resveratrol with or without CS exposure on decreased HNE protein adducts.
Representative Western blot in the upper panel. Quantification of the HNE bands is shown
in the bottom panel. Data are expressed in arbitrary units (averages of five different
experiments ± SEM, * vs. control; # vs. CS). β-actin was used as loading control.
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Fig. 6.
Effect of resveratrol on HNE/SRB1 adducts induced by CS. Immunocytochemistry of
HaCaT cells showing localization of HNE-adducts (left column, green color), SR-B1
(central column, red color) and HNE/SR-B1 adducts (right column, yellow color) after
Resveratrol pre-treatment and CS exposure(A). Images are merged in the right panel and the
yellow color indicates overlap of the staining. These data were confirmed by
immunoprecipitation for SR-B1 (B). HaCaT cells were pre-treated with resveratrol and then
exposed to CS and cell lysates were immunoprecipitated using anti-HNE.
Immunoprecipitated proteins were separated by SDS-PAGE, and then transferred to a
nitrocellulose membrane and immunoblotted with anti-SRB1. Western blot shown is
representative of five independent experiments. Quantification of the SR-B1 bands is shown
on the right of the panel. Data are expressed in arbitrary units (averages of five different
experiments ± SEM, * vs. control; # vs. CS; p < 0.05).
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